Atlas FDA

Organ Care System (OCS™) Lung System

FDA premarket approval P160013/S002 · decided 2019-05-31

Approval details

PMA number
P160013
Supplement
S002
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Organ Care System (OCS™) Lung System
Generic name
Normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantation
Applicant
TransMedics, Inc.
Date received
2018-08-14
Decision date
2019-05-31
Days to decision
290 days
Decision code
APPR
Product code
QBA
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Andover, MA
Statement
Approval for the Organ Care System (OCS™) Lung System. The TransMedics Organ Care System (OCS) Lung is a portable, normothermic organ perfusion, ventilation and monitoring medical device indicated for preservation of standard criteria donor lung pairs and for preservation of donor lung pairs initially deemed unacceptable for procurement and transplantation based on limitations of cold static preservation. The device allows for ex vivo assessment of donor lungs prior to transplantation.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OCS Heart Leukocyte Depleting Filter (K231362)TransMedics, Inc.2023-10-31
OCS Lung Donor Flush Set (K222535)TransMedics, Inc.2022-11-18
OCS Lung Solution (K211314)TransMedics, Inc.2021-07-29